Warhogs: A History of War Profits in America

The Puritans condemned war profiteering as a Provoking Evil, George Washington feared that it would ruin the Revolution, and Franklin D. Roosevelt promised many times that he would never permit the rise of another crop of war millionaires. Yet on every occasion that American soldiers and sailors served and sacrificed in the field and on the sea, other Americans cheerfully enhanced their personal wealth by exploiting every opportunity that wartime circumstances presented. In Warhogs, Stuart D. Brandes masterfully blends intellectual, economic, and military history into a fascinating discussion of a great moral question for generations of Americans: Can some individuals rightly profit during wartime while others sacrifice their lives to protect the nation? Drawing upon a wealth of manuscript sources, newspapers, contemporary periodicals, government reports, and other relevant literature, Brandes traces how each generation in financing its wars has endeavored to assemble resources equitably, to define the ethical questions of economic mobilization, and to manage economic sacrifice responsibly. He defines profiteering to include such topics as price gouging, quality degradation, trading with the enemy, plunder, and fraud, in order to examine the different guises of war profits and the degree to which they have existed from one era to the next. This far-reaching discussion moves beyond a linear narrative of the financial schemes that have shaped this nation\u27s capacity to make war to an in-depth analysis of American thought and culture. Those scholars, students, and general readers interested in the interaction of legislative, economic, social, and technological events with the military establishment will find no other study that so thoroughly surveys the story of war profits in America. Stuart D. Brandes is professor of history at the University of Wisconsin-Rock County. Stuart D. Brandes has written a solid, thoroughly researched, and exceedingly unemotional and restrained history of a neglected subject, carrying it through World War II with a limited consideration of the Cold War. . . . [H]is book is not to be ignored by either economic or military historians. —American Historical Review Offers a treasure of information on greed and selfishness during crises in America. —Reviews in American History A valuable addition to the historiography of the United States munitions industry and its relationship to American democracy and capitalism. —Journal of Southwest Georgia History The only comprehensive attempt to deal with the many facets of government contracting during time of military crisis through World War II. . . . This balanced account is must reading for anyone interested in American military history. —Military History of the West Stuart D. Brandes is the first scholar to tackle the complex and ever-shifting issue of war profits across nearly the entire scope of American history. This highly readable narrative asks the right questions and supplies cogent, well-reasoned answers based on impressive research and careful reflection. —Daniel E. Sutherlandhttps://uknowledge.uky.edu/upk_united_states_history/1106/thumbnail.jp

A general co-expression network-based approach to gene expression analysis: comparison and applications

<p>Abstract</p> <p>Background</p> <p>Co-expression network-based approaches have become popular in analyzing microarray data, such as for detecting functional gene modules. However, co-expression networks are often constructed by ad hoc methods, and network-based analyses have not been shown to outperform the conventional cluster analyses, partially due to the lack of an unbiased evaluation metric.</p> <p>Results</p> <p>Here, we develop a general co-expression network-based approach for analyzing both genes and samples in microarray data. Our approach consists of a simple but robust rank-based network construction method, a parameter-free module discovery algorithm and a novel reference network-based metric for module evaluation. We report some interesting topological properties of rank-based co-expression networks that are very different from that of value-based networks in the literature. Using a large set of synthetic and real microarray data, we demonstrate the superior performance of our approach over several popular existing algorithms. Applications of our approach to yeast, Arabidopsis and human cancer microarray data reveal many interesting modules, including a fatal subtype of lymphoma and a gene module regulating yeast telomere integrity, which were missed by the existing methods.</p> <p>Conclusions</p> <p>We demonstrated that our novel approach is very effective in discovering the modular structures in microarray data, both for genes and for samples. As the method is essentially parameter-free, it may be applied to large data sets where the number of clusters is difficult to estimate. The method is also very general and can be applied to other types of data. A MATLAB implementation of our algorithm can be downloaded from <url>http://cs.utsa.edu/~jruan/Software.html</url>.</p

Simultaneous Clustering of Multiple Gene Expression and Physical Interaction Datasets

Many genome-wide datasets are routinely generated to study different aspects of biological systems, but integrating them to obtain a coherent view of the underlying biology remains a challenge. We propose simultaneous clustering of multiple networks as a framework to integrate large-scale datasets on the interactions among and activities of cellular components. Specifically, we develop an algorithm JointCluster that finds sets of genes that cluster well in multiple networks of interest, such as coexpression networks summarizing correlations among the expression profiles of genes and physical networks describing protein-protein and protein-DNA interactions among genes or gene-products. Our algorithm provides an efficient solution to a well-defined problem of jointly clustering networks, using techniques that permit certain theoretical guarantees on the quality of the detected clustering relative to the optimal clustering. These guarantees coupled with an effective scaling heuristic and the flexibility to handle multiple heterogeneous networks make our method JointCluster an advance over earlier approaches. Simulation results showed JointCluster to be more robust than alternate methods in recovering clusters implanted in networks with high false positive rates. In systematic evaluation of JointCluster and some earlier approaches for combined analysis of the yeast physical network and two gene expression datasets under glucose and ethanol growth conditions, JointCluster discovers clusters that are more consistently enriched for various reference classes capturing different aspects of yeast biology or yield better coverage of the analysed genes. These robust clusters, which are supported across multiple genomic datasets and diverse reference classes, agree with known biology of yeast under these growth conditions, elucidate the genetic control of coordinated transcription, and enable functional predictions for a number of uncharacterized genes

The Changing Landscape for Stroke\ua0Prevention in AF: Findings From the GLORIA-AF Registry Phase 2

Background GLORIA-AF (Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation) is a prospective, global registry program describing antithrombotic treatment patterns in patients with newly diagnosed nonvalvular atrial fibrillation at risk of stroke. Phase 2 began when dabigatran, the first non\u2013vitamin K antagonist oral anticoagulant (NOAC), became available. Objectives This study sought to describe phase 2 baseline data and compare these with the pre-NOAC era collected during phase&nbsp;1. Methods During phase 2, 15,641 consenting patients were enrolled (November 2011 to December 2014); 15,092 were eligible. This pre-specified cross-sectional analysis describes eligible patients\u2019 baseline characteristics. Atrial fibrillation&nbsp;disease characteristics, medical outcomes, and concomitant diseases and medications were collected. Data were analyzed using descriptive statistics. Results Of the total patients, 45.5% were female; median age was 71 (interquartile range: 64, 78) years. Patients were from Europe (47.1%), North America (22.5%), Asia (20.3%), Latin America (6.0%), and the Middle East/Africa (4.0%). Most had high stroke risk (CHA2DS2-VASc [Congestive heart failure, Hypertension, Age&nbsp; 6575 years, Diabetes mellitus, previous Stroke, Vascular disease, Age 65 to 74 years, Sex category] score&nbsp; 652; 86.1%); 13.9% had moderate risk (CHA2DS2-VASc&nbsp;= 1). Overall, 79.9% received oral anticoagulants, of whom 47.6% received NOAC and 32.3% vitamin K antagonists (VKA); 12.1% received antiplatelet agents; 7.8% received no antithrombotic treatment. For comparison, the proportion of phase 1 patients (of N&nbsp;= 1,063 all eligible) prescribed VKA was 32.8%, acetylsalicylic acid 41.7%, and no therapy 20.2%. In Europe in phase 2, treatment with NOAC was more common than VKA (52.3% and 37.8%, respectively); 6.0% of patients received antiplatelet treatment; and 3.8% received no antithrombotic treatment. In North America, 52.1%, 26.2%, and 14.0% of patients received NOAC, VKA, and antiplatelet drugs, respectively; 7.5% received no antithrombotic treatment. NOAC use was less common in Asia (27.7%), where 27.5% of patients received VKA, 25.0% antiplatelet drugs, and 19.8% no antithrombotic treatment. Conclusions The baseline data from GLORIA-AF phase 2 demonstrate that in newly diagnosed nonvalvular atrial fibrillation patients, NOAC have been highly adopted into practice, becoming more frequently prescribed than VKA in&nbsp;Europe and North America. Worldwide, however, a large proportion of patients remain undertreated, particularly in&nbsp;Asia&nbsp;and North America. (Global Registry on Long-Term Oral Antithrombotic Treatment in Patients With Atrial Fibrillation [GLORIA-AF]; NCT01468701